Aug 16, 2026 08:05AM
Aug 5, 2026 10:40AM
Jul 8, 2026 09:02AM
Jun 17, 2026 07:00AM
Jun 1, 2026 11:11AM
May 19, 2026 03:14PM
May 3, 2026 08:00PM Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics’ Acquisition by UCB
Apr 17, 2026 02:00PM
Apr 17, 2026 02:00PM
Apr 15, 2026 07:00AM
Apr 13, 2026 07:00AM
Mar 27, 2026 09:00AM
Mar 27, 2026 09:00AM
Mar 24, 2026 02:46PM UCB Selects Georgia for New U.S. Biologics Manufacturing Facility; ~$5B Economic Impact and ~330 Permanent Jobs
Mar 11, 2026 07:00AM
Dec 8, 2025 07:00AM
Dec 8, 2025 07:00AM
Dec 4, 2025 08:12AM
Nov 3, 2025 04:00PM
Nov 3, 2025 04:00PM
Nov 3, 2025 04:00PM /C O R R E C T I O N -- UCB/
Oct 29, 2025 12:00PM
Oct 29, 2025 07:00AM
Oct 25, 2025 11:00AM
Oct 13, 2025 07:00AM
Sep 17, 2025 07:00AM
Sep 17, 2025 07:00AM
Sep 10, 2025 08:00AM Gen Z and Millennial Patients with Chronic Rheumatic Diseases Are Opening Up to Raise Awareness for Improved Care
Aug 29, 2025 01:15AM
Aug 5, 2025 08:00AM
Jul 8, 2025 07:00AM
Jun 27, 2025 07:00AM
Jun 20, 2025 07:00AM
Jun 17, 2025 08:22AM
Jun 12, 2025 12:30PM UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity
Jun 12, 2025 01:00AM
Jun 11, 2025 12:16PM
May 19, 2025 12:30PM
Apr 3, 2025 07:00AM
Mar 19, 2025 07:00AM
Mar 12, 2025 01:54PM
Mar 7, 2025 08:00AM BIMZELX® (bimekizumab-bkzx) Two-Year Data at AAD Showed Potential to Eliminate Draining Tunnels in Hidradenitis Suppurativa, and Reduction in Disease Burden
Mar 7, 2025 08:00AM
Feb 27, 2025 07:00AM
Jan 16, 2025 07:00AM
Dec 6, 2024 12:00PM
Nov 26, 2024 07:00AM
Nov 20, 2024 07:00AM
Nov 19, 2024 01:00AM Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
Nov 14, 2024 12:46PM

1,188,125 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All